drugset / Trial / NCT02005718

Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD

NCT02005718

Phase 3 Completed 36 enrolled St George's, University of London
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Vitamin D deficiency is common in CKD and assciated with CV complications. Endothelial dysfucntion is common in CKD and is a harbinger of atherosclerosis. The study investigated the impact of Vitamin D on endothelial fucntion and blood biomarkers in CKD.

Timeline

Start
2010-06
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 300000 iu Oral